Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.070
+0.020 (0.66%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Evaxion Market Cap
Evaxion has a market cap or net worth of $25.6 million as of October 9, 2026. It is the 35,345th most valuable company in the world and the 5,106th biggest in the United States. Its market cap has decreased by 35.56% in one year.
Market Cap
25.60M
Enterprise Value
18.71M
1-Year Change
-35.56%
Global Rank
Country Rank
#5,106 United States
Category
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $25.60M, a decrease of -86.66%. That is a compound annual growth rate of -29.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 25.60M | -35.64% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 28.94M |
| Context Therapeutics | 28.22M |
| Seres Therapeutics | 26.82M |
| ABVC BioPharma | 25.82M |
| Immutep | 25.19M |
| Quantum BioPharma | 24.83M |
| Kyntra Bio | 24.82M |
| aTyr Pharma | 24.80M |